Home > Blog > Success in rna therapies

Bold Thinking that Delivers Results for RNA Therapies

Success Stories Regulatory Submissions COVID-19 Biologics Full-Service

Current advances in RNA-based therapies hold substantial promise in treating and preventing many human diseases and disorders through curing the disease, rather than treating the symptomology like traditional therapeutics.

While many RNA therapeutics have made it to clinical trials, only a few have been approved. Veristat’s team of scientific-minded experts
have worked on over 60 RNA programs, including several approvedveristat therapeutic centers of excellence therapies. Our experience expands across the clinical development pathway in a broad range of therapeutic areas.

In this piece, learn how Veristat has supported some of our Biotech Sponsors in advancing their RNA therapeutics, including:
  • A landmark RNA approval
  • Navigating a full-service COVID-19 vaccine trial
  • Ensuring a Successful Regulatory Agency Interaction

DOWNLOAD NOW

 

Meet Veristat. Learn More.


 

6 min read

Accelerating Patient-Centric Clinical Trials Through Science-Based Planning, Delivery and Support

May 7, 2025  Veristat Events

With 90 percent of clinical trials failing to reach completion, sponsors need innovative approaches that blend...

2 min read

ASCO Annual Meeting

Apr 23, 2025  Veristat Events

Meet Veristat at the 2025 ASCO Annual Meeting 

Advancing Oncology Therapies for Patients in Need 

Veristat is proud to...